- Early StageStartup in initial stages
EQO careers
Our mission is to provide long-term sustainable biotherapeutic solutions for aquatic ecosystems.
Diagnostics
EQO is the only company capable of offering eRNA diagnostic solutions through the use of an automated collection system. EQO's automated samplers are installed onsite to collect and preserve biological material that are then shipped to EQO for analysis and replaced with new samplers.
Detection
EQO scientist extract, preserve, catalogue, and analyze genetic information to determine the stage of infestation. EQO then provides the customer with actionable information needed to efficiently treat a population of zebra mussels, whether it's a newly established population or an older infestation.
Monitoring
EQO automated collection system can be semi-permanently installed onsite to monitor population activity. Effective management of invasive species infestation requires population activity information. This can only be determined through consistent monitoring, allowing for treatment optimization and quality control.
Treatment
EQO has developed a biotherapeutic infestation treatment funded by the National Science Foundation and the U.S. Bureau of Reclamation. The product will be available to the public in late 2020. The product has limited to no off-target effects with high efficiency.
Diagnostics
EQO is the only company capable of offering eRNA diagnostic solutions through the use of an automated collection system. EQO's automated samplers are installed onsite to collect and preserve biological material that are then shipped to EQO for analysis and replaced with new samplers.
Detection
EQO scientist extract, preserve, catalogue, and analyze genetic information to determine the stage of infestation. EQO then provides the customer with actionable information needed to efficiently treat a population of zebra mussels, whether it's a newly established population or an older infestation.
Monitoring
EQO automated collection system can be semi-permanently installed onsite to monitor population activity. Effective management of invasive species infestation requires population activity information. This can only be determined through consistent monitoring, allowing for treatment optimization and quality control.
Treatment
EQO has developed a biotherapeutic infestation treatment funded by the National Science Foundation and the U.S. Bureau of Reclamation. The product will be available to the public in late 2020. The product has limited to no off-target effects with high efficiency.
EQO hasn't added any jobs yet
Get notified when EQO posts new jobs.
Brad Van Schouwen
Erika Schwarz Taylor
John Higley
Founder @eqo-austin
Pacific Biosciences • Menlo Park • $148k – $222k • yesterday
Noble Biomaterials • Scranton • $64k – $84k • 5 days ago
FlashParking • Dallas • $80k – $90k • 1 week ago
Syndax Pharmaceuticals • New York City • 1 week ago
Akebia Therapeutics • Oakland • $178k – $220k • 2 weeks ago



